Page 7,100«..1020..7,0997,1007,1017,102..7,1107,120..»

Cancer Stem Cell Research Drives Growth in RBCC’s Target Market

Posted: Published on February 22nd, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)-- Research into Cancer Stem Cells (CSC) is on the rise, fueling industry growth that Rainbow Coral Corp. (OTCBB: RBCC.OB - News) expects to translate into demand for n3D cell growth technologies. RBCC is finalizing an equity funding agreement with n3D Biosciences, the maker of a revolutionary new system that allows scientists to grow three-dimensional cell cultures more easily than ever before. The device, called the Bio-Assembler, could have an extraordinary impact on cell research worldwide, and RBCC expects to find a strong market for the device once its funding agreement with n3D is finalized. Many cancers, including breast, prostate, pancreatic, colon, brain, and lung cancers, contain a subset of stem-like cells understood to play a critical role in the development and progression of the disease. Research suggests that these cells, called Cancer Stem Cells, are able to “seed” new tumor formation and drive metastasis. Because these cells are believed to be at the root of the development and spread of cancer, they’re quickly becoming the center of cancer diagnostics and biomarkers. CSCs are resistant to a number of chemotherapy drugs and radiotherapy, and approximately 20 different strategies are currently being pursued in the hope of selectively targeting … Continue reading →

Posted in Stem Cell Research | Comments Off on Cancer Stem Cell Research Drives Growth in RBCC’s Target Market

Uncovered: Genetic cause of complex disease seen in Irish Traveller community

Posted: Published on February 22nd, 2012

Public release date: 22-Feb-2012 [ | E-mail | Share ] Contact: Karen Honey press_releases@the-jci.org 734-546-5242 Journal of Clinical Investigation Two independent groups of researchers ? one led by Adrian Clark, at Queen Mary University of London, United Kingdom; and the other led by Jean-Laurent Casanova, at The Rockefeller University, New York ? have now identified the disease-causing gene in patients with a complex inherited syndrome most commonly observed in the Irish Traveller community. As noted by Jordan Orange, at the University of Pennsylvania School of Medicine, Philadelphia, in an accompanying commentary, the new data provide deep mechanistic insight into a complex human condition and expand our understanding of the human immune and endocrine systems, both of which are disrupted in patients. Within the Irish Traveller community, several families have been found to suffer from an inherited condition characterized by failure of the adrenal glands to produce adequate amounts of steroid hormones, abnormal development (in particular, retarded growth), and a deficiency in immune cells known as NK cells. Both groups of researchers found that mutations in the MCM4 gene are responsible for this complex inherited condition. The MCM4 gene is responsible for templating a protein that is required for DNA to … Continue reading →

Comments Off on Uncovered: Genetic cause of complex disease seen in Irish Traveller community

better medical marijuana – Video

Posted: Published on February 22nd, 2012

21-02-2012 17:22 THIS VIDEO BELONGS TO THOSE THAT PRODUCED IT. IT IS NOT MINE AT ALL. I AM HONORED TO BE ALLOWED TO COPY AND PROMOTE IT. The latest and greatest information on getting everything from your medical marijuana this info will separate the patients from the pot heads, or those that claim to need pot when they are really just looking for a reason and excuse to get high, which is fine but I think they are slowing the real patients down from getting access and being seen as serious with their underlying greed. the big shock is that the dreaded male plant leaves have near the same medicinal qualities as the female. the female bud does have higher concentrations and I wont deny that fact. However the bottom line.... juicing the leaves in a good quality juicer is what this is really all about. The key to this is juicing fresh leaf and not allowing it to dry. this applies to the bud or flower as well. you can eat fresh bug and not get high, which is a shock, but it is true. To the two people that shared this information with me and took time to … Continue reading →

Posted in Cell Medicine | Comments Off on better medical marijuana – Video

Scary Side Effects for Popular Prescription Medications

Posted: Published on February 22nd, 2012

Attorney (866) 735-1102 Ext 336 Posted by Ed NormandFebruary 22, 2012 9:04 AM Most people accept the fact that there are side effects for almost all prescription medications. Often, these side effects are minor or only effect a small percentage of the population. But doctors and pharmaceutical companies still have a responsibility to the public to protect them from dangerous or defective drugs. Here are some popular prescription medications that can come with some serious side effects, courtesy of Men’s Health: Ambien. This popular prescription medication is a sleep aid, although it is becoming well known for its serious side effects. Some of the effects include “sleep eating,” memory loss and other odd behavior in general. The Food and Drug Administration (FDA) made the company add this label to Ambien’s Medication Guide: “After taking AMBIEN, you may get up out of bed while not being fully awake and do an activity that you do not know you are doing. The next morning, you may not remember that you did anything during the night.” Yikes. Chantix. This one is supposed to help patients who are trying to stop smoking. Chantix is used to help curb cravings for cigarettes. According to one … Continue reading →

Posted in Drug Side Effects | Comments Off on Scary Side Effects for Popular Prescription Medications

Nelson man's £35,000 cannabis habit leads to prison sentence

Posted: Published on February 22nd, 2012

Nelson man's £35,000 cannabis habit leads to prison sentence 12:30pm Wednesday 22nd February 2012 in News By Wendy Barlow , Court reporter A 62-YEAR-OLD man, said to have a £35,600-a-year cannabis habit, has been jailed after he was caught growing the drug again. John Patrick Corbett, who is also an alcoholic, had 24 large cannabis plants, which could potentially have yielded 630 grams of the drug, worth more than £6,000, Burnley Crown Court was told. Corbett, who is on benefits, has a long record for cannabis offences and in November 2008 was spared prison for cultivating the drug at his home and claiming it was for medicinal purposes. Three years earlier, he had been given a community rehabilitation order for cultivating cannabis. The defendant, said to smoke £100 of cannabis a day, this time asked for help from the probation service again, but was jailed for 26 weeks instead. Corbett, of Clover Hill Road, Nelson, had admitted producing cannabis, last October. Silvia Dacre, prosecuting, told the court the cannabis farm, with 15 plants ready and nine growing, was not a very pro-fessional set-up. She said: “It was a bit shambolic, really.” The drugs could have been worth £6,300. Weighing scales … Continue reading →

Posted in Drug Dependency | Comments Off on Nelson man's £35,000 cannabis habit leads to prison sentence

New Site Answers Hard Questions about Addiction

Posted: Published on February 22nd, 2012

ProjectKnow.com Offers Vast Library of Information on Drug and Alcohol Abuse, Addiction, and Recovery Los Angeles, CA (PRWEB) February 22, 2012 ProjectKnow.com announced today the launch of its new website dedicated to answering hard questions that site visitors may have concerning substance and alcohol use. The new and improved website is intended to further the ProjectKnow.com goal of educating people about the causes, effects, symptoms and treatments for drug and alcohol abuse and addiction. Evalyn Smith, the Knowledge Manager of ProjectKnow.com, spoke about the goals of the new website: "ProjectKnow.com is about more than just providing information about drug and alcohol addiction and substance abuse treatment,” she said. “It’s something we do extremely well, but it’s also about fostering a community where visitors can ask real-world questions and get real help from their peers—people with a very personal stake in recovery." ProjectKnow.com makes a wealth of information on drug and alcohol use available to the site’s visitors to allow for extensive research into all aspects of dependency. From alcohol to street drugs to prescription drug abuse, with the amount of available information, visitors can learn how to identify whether they or someone they know has a drug-related problem. Once the … Continue reading →

Posted in Drug Dependency | Comments Off on New Site Answers Hard Questions about Addiction

£140,000 sex drugs seized in raids

Posted: Published on February 22nd, 2012

A haul of suspected counterfeit sex drugs worth an estimated £140,000 has been found in police raids. Around 28,000 suspected counterfeit erectile dysfunction tablets were seized by the Medicines and Healthcare products Regulatory Agency (MHRA) enforcement team following co-ordinated raids at three homes. The raids took place as part of Operation Fitzroy, with the assistance of Leicestershire Police, at homes in Albert Street and Moor Lane in Loughborough, along with the Metropolitan Police in Frazier Street, south east London. Two men have been arrested and drugs with an estimated value of £140,000 were seized. It is suspected that the haul included around 6,000 counterfeit Cialis tablets, used to treat erectile dysfunction, although this needs to be confirmed by testing, the MHRA said. Danny Lee-Frost, head of operations at the MHRA, said: "These raids demonstrate the MHRA's commitment to finding those attempting to deal with falsified medicines and send a very clear message that those responsible will not benefit from their criminality. "It is the role of the MHRA to ensure the public have access to acceptably safe medicines and this action has prevented potentially unsafe medicines from reaching the public." See the original post here: £140,000 sex drugs seized in … Continue reading →

Posted in Drugs | Comments Off on £140,000 sex drugs seized in raids

Health Plans in Michigan Get Creative with Their Pharmacy Benefits Management

Posted: Published on February 22nd, 2012

NASHVILLE, Tenn.--(BUSINESS WIRE)-- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that Michigan health plans are coming up with creative ways to manage their pharmacy benefits. Priority Health has formed an oncology patient centered medical home that will test a new payment reform system for chemotherapy drugs, according to the Michigan Health Plan Analysis. Another example of creative pharmacy benefit management is Health Alliance Plan’s Hospital Readmission Avoidance program launched in January 2012. Under this plan clinical pharmacists will be integral in preventing hospital readmissions for the plan’s most chronically ill Medicare members, according to the report. “With clinical guidelines being encouraged by health plans, the pharmaceutical industry will see opportunities to advocate for their drugs to be used in treatment plans,” says Betsy Dooley, market analyst with HealthLeaders-InterStudy. The Michigan Health Plan Analysis also answers the following key questions: What new plan design yielded high enrollment for BC/BS of Michigan in 2011? What factors contributed to regional and national health plans gaining enrollment between 2010 and 2011? What lawsuit could potentially alter competition within Michigan's health insurance industry? Why Pharmaceutical Company Managed Markets Teams Need Health Plan Analysis Health Plan Analysis identifies key health plan trends, allowing … Continue reading →

Posted in Pharmacy | Comments Off on Health Plans in Michigan Get Creative with Their Pharmacy Benefits Management

VistaGen Therapeutics Engages MissionIR as Its Investor Relations Advisor

Posted: Published on February 22nd, 2012

ATLANTA, GA--(Marketwire -02/21/12)- VistaGen Therapeutics, Inc. (OTC.BB: VSTA.OB - News) (OTCQB: VSTA.OB - News), a biotechnology company applying stem cell technology for drug rescue and cell therapy, has retained MissionIR, a national investor relations consulting firm, to develop and implement a strategic investor relations campaign. Through a network of investor-oriented online websites and full suite of investor awareness services, MissionIR broadens the influence of publicly traded companies and enhances their ability to attract growth capital and improve shareholder value. "VistaGen's work with human stem cell technology is groundbreaking," said Sherri Snyder, Director of Marketing at MissionIR. "The company's versatile platform, Human Clinical Trials in a Test Tube™, provides clinically relevant predictions of potential heart toxicity of new drug candidates long before they are ever tested on humans. Guided by a management team with decades of experience, VistaGen's stem cell technology can potentially save billions of dollars in the healthcare industry while recapturing prior R&D investment in once-promising new drug candidates." "We are pleased to bring MissionIR on board as our external investor relations partner," said Shawn Singh, VistaGen's Chief Executive Officer. "The crucial work our company is doing can fundamentally change the way medicine is developed. Paired with MissionIR's global … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on VistaGen Therapeutics Engages MissionIR as Its Investor Relations Advisor

Editor’s move sparks backlash

Posted: Published on February 22nd, 2012

Bioethicist Glenn McGee’s new job raised questions of conflict of interest at the journal he founded. J. WILSON/KRT/NEWSCOM The field of bioethics is embroiled in a period of soul-searching, sparked by a startling career move by one of its biggest names. Glenn McGee is the editor-in-chief of the American Journal of Bioethics (AJOB), the most cited bioethics journal, which he founded in 1999. Since December 2011, he has also been president for ethics and strategic initiatives at CellTex Therapeutics in Houston, Texas, a controversial company involved in providing customers with unproven stem-cell therapies. A CellTex press release says that “Dr McGee’s responsibilities will include ensuring that all of the firm’s work, centered on adult stem cells, will meet the highest ethical standards of the medical and scientific communities.” Although McGee has said he will leave the journal on 1 March, many bioethicists have criticized him, the journal’s editorial board and its publisher, London-based Taylor and Francis. They argue that in holding both posts, McGee has a conflict of interest between his responsibilities to the journal and his new employer’s desire to promote the clinical application of stem-cell treatments that are not approved by the US Food and Drug Administration. “Imagine … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Editor’s move sparks backlash

Page 7,100«..1020..7,0997,1007,1017,102..7,1107,120..»